Cynata Completes Clinical Study Report for Phase 1 Trial of CYP-001 in GvHD – GlobeNewswire
Cynata Completes Clinical Study Report for Phase 1 Trial of CYP-001 in GvHD GlobeNewswireMELBOURNE, Australia, Dec. 18, 2018 (GLOBE NEWSWIRE) — Cynata Therapeutics Limited (ASX: CYP), a clinical-stage biotechnology company specializing …
